Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical Outcomes

Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical Outcomes

ABSTRACT Background Schlafen 11 (SLFN‐11) has been identified as a sensitizer of tumor cells to DNA‐damaging agents. However, the relationship between SLFN‐11 expression and clinical outcomes in patients with small cell lung cancer (SCLC) remains unexplored. Thus, we aimed to evaluate the impact of...

Full description

Saved in:
Bibliographic Details
Main Authors: Ken Masuda, Tatsuya Yoshida, Noriko Motoi, Yuki Shinno, Yuji Matsumoto, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Shun‐ichi Watanabe, Tomoaki Hoshino, Yasushi Yatabe, Yuichiro Ohe
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Thoracic Cancer
Subjects:
immunohistochemistry
lung cancer
Schlafen 11
small cell lung cancer
Online Access:https://doi.org/10.1111/1759-7714.15529
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/1759-7714.15529

Similar Items